Abbott Lowers 2026 Sales Growth Forecast to About 6%
Abbott lowered its 2026 sales growth forecast to about 6%, from a prior range of 6.5% to 7.5%, citing softer-than-expected demand for medical devices.
Abbott Laboratories NYSE:ABT lowered its annual sales growth forecast on Wednesday, after reporting softer-than-expected demand for its medical devices.The company now expects 2026 sales growth of about 6%, compared with its prior expectation of between 6.5% and 7.5%.The medtech giant reported quar…